Joshua Olson

3.8k total citations · 1 hit paper
53 papers, 2.9k citations indexed

About

Joshua Olson is a scholar working on Molecular Biology, Infectious Diseases and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Joshua Olson has authored 53 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 15 papers in Infectious Diseases and 14 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Joshua Olson's work include Antimicrobial Resistance in Staphylococcus (14 papers), Streptococcal Infections and Treatments (13 papers) and Bacterial biofilms and quorum sensing (9 papers). Joshua Olson is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (14 papers), Streptococcal Infections and Treatments (13 papers) and Bacterial biofilms and quorum sensing (9 papers). Joshua Olson collaborates with scholars based in United States, Germany and Sweden. Joshua Olson's co-authors include Victor Nizet, George Sakoulas, Liangfang Zhang, Brian T. Luk, Tamara Escajadillo, Poochit Nonejuie, Pavimol Angsantikul, Soracha Thamphiwatana, Ross Corriden and Joseph Pogliano and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Joshua Olson

52 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Macrophage-like nanoparticles concurrently absorbing endotoxins and proinflammatory cytokines for sepsis management

2017 467 citations Joshua Olson, Victor Nizet et al. Proceedings of the National Academy of Sciences profile →

Peers

Countries citing papers authored by Joshua Olson

Since Specialization

Citations

This map shows the geographic impact of Joshua Olson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joshua Olson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joshua Olson more than expected).

Fields of papers citing papers by Joshua Olson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joshua Olson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joshua Olson. The network helps show where Joshua Olson may publish in the future.

Co-authorship network of co-authors of Joshua Olson

This figure shows the co-authorship network connecting the top 25 collaborators of Joshua Olson. A scholar is included among the top collaborators of Joshua Olson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joshua Olson. Joshua Olson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Ethylenediaminetetraacetic Acid Enhances Vancomycin and Reactive Oxygen Species–Mediated Killing of Vancomycin-Intermediate Staphylococcus aureus 2025 ·Open Forum Infectious Diseases ·Joshua Olson, (unknown), Allen Jankeel, (unknown), Victor Nizet, George Sakoulas, Erlinda R. Ulloa	0
2	Anesthetic choice impacts mortality and bacterial clearance in a murine experimental pneumonia model 2025 ·BMC Infectious Diseases ·(unknown), (unknown), Bryan Hancock, Ingrid Cornax, Jason Munguia, Joshua Olson, Elisabet Bjånes, (unknown), (unknown), Fatemeh Askarian, Kathleen Tong, Lin Liu, Victor Nizet, Angela Meier	1
3	Promptology: Enhancing Human–AI Interaction in Large Language Models 2024 ·Information ·Phillip Olla, (unknown), (unknown), (unknown), Joshua Olson	1
4	Repurposed drugs block toxin-driven platelet clearance by the hepatic Ashwell-Morell receptor to clear Staphylococcus aureus bacteremia 2021 ·Science Translational Medicine ·(unknown), Satoshi Uchiyama, Joshua Olson, Yosuke Morodomi, Ingrid Cornax, (unknown), (unknown), (unknown), (unknown), Nina M. Haste, Sachiko Kanaji, Taisuke Kanaji, Warren E. Rose, George Sakoulas, Jamey D. Marth, Victor Nizet	33
5	Novel Models of Streptococcus canis Colonization and Disease Reveal Modest Contributions of M-Like (SCM) Protein 2021 ·Microorganisms ·Ingrid Cornax, (unknown), Joshua Olson, Marcus Fulde, Victor Nizet, Kathryn A. Patras	3
6	TLR4 signaling and macrophage inflammatory responses are dampened by GIV/Girdin 2020 ·Proceedings of the National Academy of Sciences ·(unknown), Gajanan D. Katkar, (unknown), (unknown), (unknown), (unknown), (unknown), Vanessa Castillo, Joshua Olson, Victor Nizet, Irina Kufareva, Soumita Das, Pradipta Ghosh	72
7	Mortality Risk Profiling of Staphylococcus aureus Bacteremia by Multi-omic Serum Analysis Reveals Early Predictive and Pathogenic Signatures 2020 ·Cell ·Jacob M. Wozniak, Robert H. Mills, Joshua Olson, J.R. Caldera, Gregory D. Sepich‐Poore, Marvic Carrillo-Terrazas, Chih‐Ming Tsai, Fernando Vargas, Rob Knight, Pieter C. Dorrestein, George Y. Liu, Victor Nizet, George Sakoulas, Warren E. Rose, David J. Gonzalez	71
8	The Pseudomonas aeruginosa protease LasB directly activates IL-1β 2020 ·EBioMedicine ·(unknown), Doris L. LaRock, (unknown), Jacqueline M. Kimmey, Joshua Olson, Zhenze Jiang, Anthony J. O’Donoghue, Victor Nizet, Christopher N. LaRock	41
9	Paired Siglec receptors generate opposite inflammatory responses to a human‐specific pathogen 2017 ·The EMBO Journal ·Flavio Schwarz, (unknown), Shoib Sarwar Siddiqui, Ismael Secundino, Joshua Olson, Nissi Varki, Victor Nizet, Ajit Varki	62
10	Tamm–Horsfall glycoprotein engages human Siglec‐9 to modulate neutrophil activation in the urinary tract 2017 ·Immunology and Cell Biology ·Kathryn A. Patras, Alison Coady, Joshua Olson, Syed R. Ali, Satish RamachandraRao, Satish Kumar, Ajit Varki, Victor Nizet	26
11	The Mla pathway is critical for Pseudomonas aeruginosa resistance to outer membrane permeabilization and host innate immune clearance 2017 ·Journal of Molecular Medicine ·Jason Munguia, Doris L. LaRock, Hannah Tsunemoto, Joshua Olson, Ingrid Cornax, Joseph Pogliano, Victor Nizet	30
12	Role of Hypoxia Inducible Factor-1α (HIF-1α) in Innate Defense against Uropathogenic Escherichia coli Infection 2015 ·PLoS Pathogens ·Ann E. Lin, Federico C. Beasley, Joshua Olson, Nadia Keller, Robert A. Shalwitz, Thomas J. Hannan, Scott J. Hultgren, Victor Nizet	61
13	Tamoxifen augments the innate immune function of neutrophils through modulation of intracellular ceramide 2015 ·Nature Communications ·Ross Corriden, Andrew Hollands, Joshua Olson, (unknown), Justine Lopez, John T. Chang, David J. Gonzalez, Victor Nizet	95
14	Group A Streptococcal M1 Protein Sequesters Cathelicidin to Evade Innate Immune Killing 2015 ·Cell Host & Microbe ·Christopher N. LaRock, Simon Döhrmann, (unknown), Ross Corriden, Joshua Olson, Timo Johannssen, Bernd Lepenies, Richard L. Gallo, Partho Ghosh, Victor Nizet	45
15	Antimicrobial Salvage Therapy for Persistent Staphylococcal Bacteremia Using Daptomycin Plus Ceftaroline 2014 ·Clinical Therapeutics ·George Sakoulas, Pamela Moise, Anthony M. Casapao, Poochit Nonejuie, Joshua Olson, Cheryl Okumura, Michael J. Rybak, Ravina Kullar, Abhay Dhand, Warren E. Rose, Debra A. Goff, Adam Bressler, (unknown), Joseph Pogliano, Scott Johns, Glenn W. Kaatz, John R. Ebright, Victor Nizet	139
16	Role of macrophage sialoadhesin in host defense against the sialylated pathogen group B Streptococcus 2014 ·Journal of Molecular Medicine ·Yung‐Chi Chang, Joshua Olson, (unknown), Paul R. Crocker, Ajit Varki, Victor Nizet	38
17	Group B Streptococcus Engages an Inhibitory Siglec through Sialic Acid Mimicry to Blunt Innate Immune and Inflammatory Responses In Vivo 2014 ·PLoS Pathogens ·Yung‐Chi Chang, Joshua Olson, Federico C. Beasley, (unknown), Jiquan Zhang, Paul R. Crocker, Ajit Varki, Victor Nizet	109
18	Nafcillin enhances innate immune-mediated killing of methicillin-resistant Staphylococcus aureus 2013 ·Journal of Molecular Medicine ·George Sakoulas, Cheryl Okumura, Wdee Thienphrapa, Joshua Olson, Poochit Nonejuie, Quang Dam, Abhay Dhand, Joseph Pogliano, Michael R. Yeaman, Mary E. Hensler, Arnold S. Bayer, Victor Nizet	108
19	Myeloid cell HIF-1α regulates asthma airway resistance and eosinophil function 2012 ·Journal of Molecular Medicine ·Laura E. Crotty Alexander, (unknown), Stephanie Feldstein, Per Johansson, Anh Nguyen, Elisa McEachern, (unknown), Andrew S. Cowburn, Joshua Olson, Jae Youn Cho, Hart Isaacs, Randall S. Johnson, David H. Broide, Victor Nizet	54
20	Page Ranking Refinement Using Fuzzy Sets and Logic. 2011 ·Andrew J. Laughlin, Joshua Olson, (unknown), Atsushi Inoue	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact